133 related articles for article (PubMed ID: 7398002)
1. Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group.
Circulation; 1980 Sep; 62(3):449-61. PubMed ID: 7398002
[TBL] [Abstract][Full Text] [Related]
2. [Persantin and aspirin in coronary heart disease. The persantin-aspirin reinfarction study group (PARIS)].
MMW Munch Med Wochenschr; 1980 Dec; 122(49):1761-71. PubMed ID: 6779148
[TBL] [Abstract][Full Text] [Related]
3. Persantine-Aspirin Reinfarction Study. Part II. Secondary coronary prevention with persantine and aspirin.
Klimt CR; Knatterud GL; Stamler J; Meier P
J Am Coll Cardiol; 1986 Feb; 7(2):251-69. PubMed ID: 2868029
[TBL] [Abstract][Full Text] [Related]
4. The Persantine-aspirin reinfarction study. The Persantine-aspirin Reinfarction Study (PARIS) research group.
Circulation; 1980 Dec; 62(6 Pt 2):V85-8. PubMed ID: 7002354
[TBL] [Abstract][Full Text] [Related]
5. Persantine-aspirin reinfarction study. Design, methods and baseline results. By the persantine-aspirin reinfarction study research group.
Circulation; 1980 Sep; 62(3 Pt 2):II1-42. PubMed ID: 7408140
[TBL] [Abstract][Full Text] [Related]
6. "AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia.
Bousser MG; Eschwege E; Haguenau M; Lefaucconnier JM; Thibult N; Touboul D; Touboul PJ
Stroke; 1983; 14(1):5-14. PubMed ID: 6401878
[TBL] [Abstract][Full Text] [Related]
7. [Various observations on the results of the "Aspirin myocardial infarction study" and the "Persantine-aspirin reinfarction study" in the United States].
Lubsen J
Ned Tijdschr Geneeskd; 1981 Oct; 125(40):1606-9. PubMed ID: 7029311
[No Abstract] [Full Text] [Related]
8. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
Serebruany VL; Malinin AI; Pokov AN; Hanley DF
Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
[TBL] [Abstract][Full Text] [Related]
9. Persantine Aspirin Trial in cerebral ischemia. Part II: Endpoint results. The American-Canadian Co-Operative Study group.
Stroke; 1985; 16(3):406-15. PubMed ID: 2860740
[TBL] [Abstract][Full Text] [Related]
10. Secondary prevention of myocardial infarction.
Davies JA
Int J Clin Pharmacol Res; 1985; 5(5):303-7. PubMed ID: 3905632
[TBL] [Abstract][Full Text] [Related]
11. Aspirin in coronary heart disease. The Coronary Drug Project Research Group.
Circulation; 1980 Dec; 62(6 Pt 2):V59-62. PubMed ID: 7002353
[TBL] [Abstract][Full Text] [Related]
12. A trial of dipyridamole and aspirin in the prevention of smoking-induced changes in platelets and endothelium in men with coronary artery disease.
Davis JW; Hartman CR; Shelton L; Ruttinger HA
Am J Cardiol; 1989 Jun; 63(20):1450-4. PubMed ID: 2524959
[TBL] [Abstract][Full Text] [Related]
13. The German-Austrian aspirin trial: a comparison of acetylsalicylic acid, placebo and phenprocoumon in secondary prevention of myocardial infarction. On behalf of the German-Austrian Study Group.
Breddin K; Loew D; Lechner K; Oberla K; Walter E
Circulation; 1980 Dec; 62(6 Pt 2):V63-72. PubMed ID: 6777073
[TBL] [Abstract][Full Text] [Related]
14. Effects of antiplatelet therapy with indobufen or aspirin-dipyridamole on graft patency one year after coronary artery bypass grafting.
Rajah SM; Nair U; Rees M; Saunders N; Walker D; Williams G; Critchley A; Beton D; Campbell C; Lawson RA
J Thorac Cardiovasc Surg; 1994 Apr; 107(4):1146-53. PubMed ID: 8159037
[TBL] [Abstract][Full Text] [Related]
15. Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: the Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS).
Diener HC; Sacco R; Yusuf S; ;
Cerebrovasc Dis; 2007; 23(5-6):368-80. PubMed ID: 17337887
[TBL] [Abstract][Full Text] [Related]
16. Antiplatelet therapy and progression of coronary artery disease: a placebo-controlled trial with angiographic and clinical follow-up after myocardial infarction.
Dieker HJ; French JK; Joziasse IC; Brouwer MA; Elliott J; West TM; Webber BJ; Verheugt FW; White HD
Am Heart J; 2007 Jan; 153(1):66.e1-8. PubMed ID: 17174639
[TBL] [Abstract][Full Text] [Related]
17. A randomized, controlled trial of aspirin in persons recovered from myocardial infarction.
JAMA; 1980 Feb; 243(7):661-9. PubMed ID: 6985998
[TBL] [Abstract][Full Text] [Related]
18. Randomised placebo controlled trial of aspirin and dipyridamole in the prevention of coronary vein graft occlusion.
Brooks N; Wright J; Sturridge M; Pepper J; Magee P; Walesby R; Layton C; Honey M; Balcon R
Br Heart J; 1985 Feb; 53(2):201-7. PubMed ID: 3881108
[TBL] [Abstract][Full Text] [Related]
19. Clinical trials on the efficacy of pharmacologic intervention reducing mortality from cardiovascular diseases.
Borhani NO
Cardiology; 1985; 72(5-6):366-75. PubMed ID: 2866843
[TBL] [Abstract][Full Text] [Related]
20. Dipyridamole for preventing recurrent ischemic stroke and other vascular events: a meta-analysis of individual patient data from randomized controlled trials.
Leonardi-Bee J; Bath PM; Bousser MG; Davalos A; Diener HC; Guiraud-Chaumeil B; Sivenius J; Yatsu F; Dewey ME;
Stroke; 2005 Jan; 36(1):162-8. PubMed ID: 15569877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
